Elliott Takes Major Stake in Align Technology, Shares Jump 4%
Elliott Investment Management has built a major stake in Align Technology, becoming one of the company’s largest investors and sending shares up about 4%. Barclays analysts forecast dental markets may stabilize this year, potentially supporting a recovery after the steep decline from the 2021 pandemic peak.
1. Activist Stake
Elliott Investment Management has quietly built a significant position in Align Technology, emerging as one of its largest shareholders. The news triggered a near 4% gain in the stock as the activist fund prepares to engage with management on strategies to lift the share price.
2. Historical Valuation Decline
Align shares peaked at $729.92 in mid-2021 amid pandemic-driven demand for cosmetic dental treatments before a steady decline to around $172, valuing the company at approximately $12.3 billion. The drop reflects waning consumer interest as videoconferencing trends normalized.
3. Market Stabilization Indicators
Analysts at Barclays project that dental markets may find a floor this year and estimate Align could trade closer to 12 times EBITDA by 2027, up from roughly 10 times today. This potential multiple expansion could signal upside if procedure volumes recover.
4. Potential Activist Objectives
Elliott is expected to press Align’s leadership for operational or strategic changes aimed at accelerating revenue growth and improving profitability. Such moves could include cost optimization, new product initiatives or capital allocation adjustments to enhance shareholder value.